Nevertheless, the G6PD role in onset and progression of tumor lesions in living patients is markedly less obvious, since even severe G6PD deficiency (down to < 1% of normal activity) does not decrease cancer incidence5,6 and can even increase mortality for several cancer types7. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.